Dexbrompheniramine, Pseudoephedrine

Coricidin 'D' Nasal and Sinus Congestion

6 MG + 120 MG Tablet (Extended-Release)CanadaCancelled

Open in the registerAsk Osler about it

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Disophrol S-A TabSaudi Arabia · Schering-PloughSame form
BrompherilUnited States · 6MG; 120MG · tablet, extended release · Copley PharmSame form
Dexbrompheniramine Maleate and Pseudoephedrine SulfateUnited States · 6MG; 120MG · tablet, extended release · Avanthi INCSame form
DisobromUnited States · 6MG; 120MG · tablet, extended release · SandozSame form

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Dexbrompheniramine, Pseudoephedrine

Coricidin 'D' Nasal and Sinus Congestion

6 MG + 120 MG Tablet (Extended-Release)CanadaCancelled

Open in the registerAsk Osler about it

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Register entryHealth Canada

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substances: Dexbrompheniramine, Pseudoephedrine
Strength: 6 MG + 120 MG
Dosage form: Tablet (Extended-Release)
Route: Oral
Register: Canada (Health Canada)
Status: Cancelled
Status in the register: Cancelled Pre Market
Registration: DIN 02244303
Marketing authorisation holder: Schering-Plough Healthcare Products Canada, A Division of Schering Canada INC.
ATC code: R01BA52
Group: Respiratory system
Supply: NON-PRESCRIPTION DRUGS

CanadaCancelled

Drixoral Day/Night - SRT/TabsDexbrompheniramine + Pseudoephedrine · 2 MG + 60 MG + 120 MG · Tablet, Tablet (Extended-Release)CanadaCancelled

Drixoral SyrupDexbrompheniramine + Pseudoephedrine · 1.5 MG / 5 ML + 30 MG / 5 ML · SyrupCanadaCancelled

Drixtab TabDexbrompheniramine + Pseudoephedrine · 2 MG + 60 MG · TabletCanadaCancelled